scholarly journals Results of a phase II study evaluating monalizumab in combination with cetuximab in previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)

2018 ◽  
Vol 29 ◽  
pp. viii374 ◽  
Author(s):  
J. Fayette ◽  
G. Lefebvre ◽  
M.R. Posner ◽  
J. Bauman ◽  
S. Salas ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Metastatic Squamous Cell Carcinoma ◽  
Previously Treated

Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) previously treated with platinum-based therapy.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 6051-6051
Author(s):  
Sylvie Rottey ◽  
Aline Van Maanen ◽  
Jean-Marie Vandenbulcke ◽  
Bertrand Filleul ◽  
Emmanuel Seront ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Randomized Phase Ii ◽  
Metastatic Squamous Cell Carcinoma ◽  
Previously Treated

scholarly journals Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum‐Based Therapy

2016 ◽  
Vol 21 (12) ◽  
pp. 1416 ◽  
Author(s):  
Jean‐Pascal Machiels ◽  
Aline Van Maanen ◽  
Jean‐Marie Vandenbulcke ◽  
Bertrand Filleul ◽  
Emmanuel Seront ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Randomized Phase Ii ◽  
Metastatic Squamous Cell Carcinoma ◽  
Previously Treated

Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens

Oral Oncology ◽  
2010 ◽  
Vol 46 (11) ◽  
pp. 818-821 ◽  
Author(s):  
Elena Massa ◽  
Mariele Dessì ◽  
Giulio Gaspardini ◽  
Federica Saba ◽  
Valeria Cherchi ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Metastatic Squamous Cell Carcinoma

Abstract C166: Phase II study of cetuximab and lenalidomide in recurrent/metastatic squamous cell carcinoma of the head and neck.

2013 ◽  
Author(s):  
Rodney J. Taylor ◽  
Vassiliki Saloura ◽  
Richard Wong ◽  
Olga Goloubeva ◽  
Lorna Silpino ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Metastatic Squamous Cell Carcinoma

scholarly journals Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study

2019 ◽  
Vol 123 ◽  
pp. 36-47 ◽  
Author(s):  
Martin D. Forster ◽  
Magnus T. Dillon ◽  
Judit Kocsis ◽  
Éva Remenár ◽  
Gabor Pajkos ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Metastatic Squamous Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document